Coronary Stents Market Set for Steady Growth at 3.2% CAGR Through 2031, Led by North America's High 35% Global Market Share | DataM Intelligence

The Coronary Stents Market is estimated to grow at a CAGR of 3.2% during the forecast period 2024-2031.

Market growth stems from the rising prevalence of cardiovascular diseases worldwide, advancements in stent technologies like drug-eluting and bioresorbable variants, and an expanding elderly population driving demand for minimally invasive procedures.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/coronary-stents-market?ram

United States: Key Industry Developments
✅ December 2025: Boston Scientific launched the EluviaTM next-generation drug-eluting coronary stent, featuring advanced polymer technology for reduced restenosis rates and improved long-term patency in complex lesions.

✅ October 2025: Medtronic received FDA approval for the Onyx FrontierTM stent, optimized for smaller vessels with enhanced deliverability and radial strength to support high-risk PCI procedures.

✅ August 2025: Abbott expanded its Xience family with a bioresorbable polymer variant, emphasizing faster endothelialization and lower thrombosis risk based on pivotal trial data.

Asia Pacific / Japan: Key Industry Developments
✅ November 2025: Terumo Corporation introduced the Ultimaster TanseiTM drug-eluting stent in Japan, with a biodegradable polymer and thin struts for better conformability in Asian patient anatomies.

✅ September 2025: Medtronic partnered with Terumo to roll out a polymer-free coronary stent across Asia Pacific markets, targeting rapid healing and reduced dual antiplatelet therapy duration.

✅ July 2025: Japan-basedLepu Medical debuted its drug-eluting stent with sirolimus elution in APAC, focusing on cost-effective innovation amid rising PCI volumes.

Key Merges and Acquisitions(2025):
✅ Leading players in the coronary stents market pursued strategic acquisitions in 2025 to integrate advanced intravascular lithotripsy technologies, enhancing treatment outcomes for complex calcified lesions.

✅ Major firms expanded their vascular intervention portfolios through high-value purchases of drug-coated balloon and resorbable scaffold assets, strengthening end-to-end coronary offerings.

✅ Industry consolidators focused on M&A to acquire innovative stent systems and digital imaging analytics capabilities, targeting growth in the $10 billion interventional cardiology segment.

Market Segmentation Analysis:
-By Product Type: Drug-Eluting Stents Dominate Amid Low Restenosis
Drug-eluting stents (DES) hold the largest share at 76% in 2025, favored for superior restenosis prevention via drug release coatings in PCI procedures. Bare-metal stents capture 15%, valued for rapid endothelialization and cost-effectiveness in high-bleeding-risk patients. Bioabsorbable stents account for 9%, gaining ground with vessel restoration potential despite deployment challenges.

-By Material: Metallic Leads for Durability
Metallic materials command 70% share, driven by cobalt-chromium (46%) and platinum-chromium alloys offering strength, flexibility, and radiopacity. Polymeric holds 20%, supporting bioresorbable scaffolds with controlled degradation. Natural biomaterials and others split 10%, niche for biocompatibility trials.

-By End-User: Hospitals Drive Procedural Volume
Hospitals lead with 65% share, central to complex PCI and cath lab infrastructure. Cardiac specialty clinics take 25%, excelling in elective cases. Ambulatory surgical centers claim 10%, rising for outpatient efficiency.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=coronary-stents-market?ram (Purchase 2 or more Reports and get 50% Discount)

Why is the Coronary Stents Market Growing?
The rapid expansion of the Coronary Stents market in 2026 is fueled by several critical factors:
-Surging Cardiovascular Disease Prevalence
Rising incidence of coronary artery diseases worldwide, driven by sedentary lifestyles, obesity, diabetes, and poor diets, boosts demand for stents as minimally invasive interventions.

-Aging Global Population
Older adults face higher risks of heart conditions, making them prime candidates for stenting procedures that offer quick recovery over traditional surgery.

-Technological Innovations
Advancements in drug-eluting, bioresorbable, and bioengineered stents improve efficacy, reduce complications, and enhance deliverability.

-Government and Regional Support
Increased healthcare spending, insurance coverage, and infrastructure upgrades especially in Asia-Pacific nations like China and India, accelerate adoption.

Regional Insights:
-North America holds the largest share of the global coronary stents market, generally in the high 35% range, driven by high coronary artery disease prevalence, advanced PCI infrastructure, favorable reimbursement, and rapid adoption of newer drug‐eluting stents and image‐guided interventions. Within North America, the United States accounts for the clear majority of regional revenue due to high procedure volumes, strong hospital purchasing power, and continuous product innovation and approvals in interventional cardiology.

-Europe typically emerges as the second‐largest regional market by share, supported by a large burden of cardiovascular disease, established catheterization lab networks, and broad availability of drug‐eluting stents under various national healthcare systems. European growth is steadier than North America, with pricing pressures, reference pricing, and stringent regulatory pathways moderating value growth even as procedure volumes remain high across major markets such as Germany, France, the U.K., and Italy.

-Asia Pacific is usually positioned as the third‐largest region in current revenue terms but is highlighted as the fastest‐growing market, with rising PCI penetration in China, India, and Southeast Asia, expanding hospital infrastructure, and gradual adoption of premium drug‐eluting and bioresorbable technologies.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/coronary-stents-market?ram

Key Players:
Abbott Laboratories | B. Braun Medical Inc. | Biosensors International Group Ltd | BIOTRONIK SE & Co. KG | Boston Scientific Corporation | Cook Medical Technologies | Medtronic PLC | Terumo Corporation | Transluminal GmbH | Cardinal Health

Key Highlights (Top 5 Key Players) for Coronary Stents Market:
-Abbott Laboratories develops advanced drug-eluting stents like the XIENCE family, focusing on improved patient outcomes through innovative coatings and delivery systems for treating coronary artery disease.

-Boston Scientific Corporation pioneers next-generation stents including drug-eluting and bioresorbable options, emphasizing minimally invasive technologies to reduce restenosis and enhance long-term vessel patency.

-Medtronic PLC offers a broad portfolio of coronary stents such as the Resolute series, integrating durable polymers and bioactive agents to support endothelialization and lower thrombosis risks in percutaneous interventions.

-B. Braun Medical Inc. manufactures high-quality balloon-expandable and self-expanding stents, prioritizing precision engineering for complex lesions and optimal radial force in peripheral and coronary applications.

-BIOTRONIK SE & Co. KG specializes in bioengineered stents like Orsiro, featuring biodegradable polymers and limus-eluting tech to promote rapid healing and minimize inflammation in high-risk patients.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ram

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.